Status:
COMPLETED
Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
This study is conducted in Africa. The aim of this study is to assess the safety and efficacy of Levemir® treatment for insulin naive patients with type 2 diabetes under normal clinical practice condi...
Eligibility Criteria
Inclusion
- Informed consent obtained before any trial-related activities
- Type 2 diabetes
- HbA1c between 7-9%
- Insulin naive
- Inadequate control with oral antidiabetics therapy as judged by investigator
Exclusion
- Patients with type 1 diabetes
- Hypersensitivity to Levemir® or to any of the excipients
- Pregnancy, or desire of pregnancy within next 6 months
- HbA1c greater than or equal to 9%
- Known or suspected allergy to the trial product or to any of the excipients
- Subjects who are unlikely to comply with protocol
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
1976 Patients enrolled
Trial Details
Trial ID
NCT00700830
Start Date
January 1 2008
End Date
September 1 2009
Last Update
August 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Algiers, Algeria, 16035